Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Aquestive Therapeutics Inc (NASDAQ: AQST) was $4.28 for the day, down -2.28% from the previous closing price of $4.38. In other words, the price has decreased by -$2.28 from its previous closing price. On the day, 1.68 million shares were traded. AQST stock price reached its highest trading level at $4.5 during the session, while it also had its lowest trading level at $4.24.
Ratios:
Our analysis of AQST’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.87 and its Current Ratio is at 2.24.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on April 11, 2024, initiated with a Overweight rating and assigned the stock a target price of $10.
On March 28, 2024, Raymond James started tracking the stock assigning a Outperform rating and target price of $7.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 15 ’24 when Schobel Alexander Mark sold 50,000 shares for $6.00 per share. The transaction valued at 300,000 led to the insider holds 984,476 shares of the business.
Schobel Alexander Mark sold 25,000 shares of AQST for $129,685 on Mar 08 ’24. The Chief Innovation/Tech Officer now owns 1,040,371 shares after completing the transaction at $5.19 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AQST now has a Market Capitalization of 385062656 and an Enterprise Value of 330506272. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.61. Its current Enterprise Value per Revenue stands at 6.534 whereas that against EBITDA is -24.072.
Stock Price History:
Over the past 52 weeks, AQST has reached a high of $6.23, while it has fallen to a 52-week low of $1.15. The 50-Day Moving Average of the stock is 6.17%, while the 200-Day Moving Average is calculated to be 77.02%.
Shares Statistics:
AQST traded an average of 2.47M shares per day over the past three months and 2484170 shares per day over the past ten days. A total of 89.97M shares are outstanding, with a floating share count of 79.79M. Insiders hold about 11.31% of the company’s shares, while institutions hold 26.41% stake in the company. Shares short for AQST as of 1711584000 were 2273072 with a Short Ratio of 0.92, compared to 1709164800 on 1811878. Therefore, it implies a Short% of Shares Outstanding of 2273072 and a Short% of Float of 3.0299999.
